Detected ·

Crystalys Therapeutics

$130M—

Crystalys Therapeutics closed an oversubscribed $130M Series B financing to advance dotinurad's late-stage global clinical development for gout. The round was led by Frazier Life Sciences, with Wellington Management, HBM Healthcare Investments, and existing investors including AN Venture Partners participating.

Website
—
Amount
$130 000 000 USD
Stage
—
Event
Funding round
Detected
2026-08-11 12:04:25 UTC
Signal ID
4fa6c5ec-1c48-4081-bc67-96649f30b08b

As the API returns it

{
  "id": "4fa6c5ec-1c48-4081-bc67-96649f30b08b",
  "created_at": "2026-08-11T12:04:25.775304Z",
  "company_name": "Crystalys Therapeutics",
  "company_website_url": null,
  "company_linkedin_url": "https://www.linkedin.com/company/crystalys-therapeutics",
  "event_type": "funding",
  "funding_amount": 130000000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*Crystalys Therapeutics closed an oversubscribed $130M Series B financing to advance dotinurad's late-stage global clinical development for gout. The round was led by Frazier Life Sciences, with Wellington Management, HBM Healthcare Investments, and existing investors including AN Venture Partners participating.*"
}

Latest rounds

FLEXECHARGE——LinkedIn
Nimesis Technology€550KOtherLinkedIn
Remanence$30MSeedLinkedIn
Noeri$110M—LinkedIn
Nimesis Technology——Site / LinkedIn
Nomadic Drones$6MSeedSite / LinkedIn
ODAIA—Series CLinkedIn
Remanence$30MSeedLinkedIn
Model ML$250MSeries BLinkedIn
Commit Biologics$60MSeedLinkedIn
Treat Health€3MPre-SeedLinkedIn
Tiberius Aerospace$85MSeries ASite / LinkedIn
Numa$45MSeries CLinkedIn
ODAIA—Series CSite / LinkedIn
Pulpex£24.6MSeries DSite / LinkedIn
Q-CTRL$290MSeries CLinkedIn
Arva AI$20MSeries ALinkedIn
Arva AI$20MSeries ASite / LinkedIn
Fairly$22.4MSeries ASite / LinkedIn
Previsia€3.8MSeedSite / LinkedIn
August AI$12M—Site / LinkedIn
MountAIn€7.3M—Site / LinkedIn
Treat Health€3M—Site / LinkedIn
Gotham FC$100MOtherSite / LinkedIn
Isomorphic Labs$5B—Site / LinkedIn
End Close$3.5MSeed—
Model ML$250MSeries BSite / LinkedIn
Remanence$30M——
Remanence$30M——
Hadl.ai——LinkedIn
Remanence€27.2MSeed—
Bricks Performance SystemDKK 1.5M—Site / LinkedIn
Noeri$110M——
Remedy Robotics$62MOtherLinkedIn
COUNT$6.5MSeedSite / LinkedIn
Nimble Science—AngelSite / LinkedIn
Corma$125MSeries A—
Bedrock Energy$24M—LinkedIn
Corma$125MSeries ALinkedIn
ComeHome—OtherSite / LinkedIn
Queens Court Capital——Site / LinkedIn
FLEXECHARGE——Site / LinkedIn
Numa$45MSeries CLinkedIn
The Vaccine Group (TVG)£500KOtherSite / LinkedIn
AgentWeb—Other—
Corma$125MSeries ALinkedIn
Geminus—Other—
Drogue—Pre-SeedSite / LinkedIn
Traitomic€20M—LinkedIn
Centese——Site / LinkedIn